Relative Contribution of Apparent Diffusion Coefficient (ADC) Values and ADC Ratios of Focal Hepatic Lesions in the Characterization of Benign and Malignant Lesions
Relative Contribution of Apparent Diffusion Coefficient (ADC) Values and ADC Ratios of Focal Hepatic Lesions in the Characterization of Benign and Malignant Lesions
Objective: The aim of the present study was to compare relative contribution of apparent diffusion coefficient (ADC) values andADC ratios (ADC of the lesion/ADC of the neighboring hepatic parenchyma) in the differential diagnosis of benign and malignantfocal hepatic lesions.Methods: A total of 80 patients with 94 focal hepatic mass lesions (mean size, 5.3 cm; range, 1–12 cm) were evaluated retrospectivelyusing 3 Tesla magnetic resonance imaging (MRI). The ADC values and ADC ratios were compared for different types of lesionsto obtain ideal cut-off values.Results: Mean ADC values (±SD) were 0.93±0.15, 0.95±0.48, 1.44±0.39, 1.88±0.50, and 2.94±0.75×10−3 mm2/sec respectively forhepatocellular carcinoma (HCC), metastasis, focal nodular hyperplasia (FNH), hemangioma, and cysts with a mean ADC value of1.97±0.68 for benign lesions and 0.94±0.29×10−3 mm2/sec for malignant lesions. The ADC ratios of benign and malignant lesionswere 1.50±0.53 and 0.80±0.20×10−3 mm2/sec, respectively, and the ADC values and ratios were found to differ significantly betweenbenign and malignant lesions. Assuming a cut-off ADC value of 1.26×10−3 mm2/sec for discrimination of benign and malignantlesions provided 94% sensitivity and 92% specificity. Sensitivity of 85% and specificity of 92% were found when a cut-off ADC ratio of 0.90×10−3 mm2/sec was used for discrimination of benign and malignant lesions. Compared to ADC values, ADC ratios werefound to have lower sensitivity and higher specificity for discriminating between benign and malignant lesions.Conclusion: Diffusion weighted imaging is used in combination with conventional MRI, and it enhances the diagnostic accuracy of MRI in the characterization of benign and malignant lesions.
___
- Koh D, Collins D. Diffusion Weighted MRI in the Body: Applications
and Challenges in Oncology. Am J Roentgenol 2007; 188:
1622-35.
- Reimer P, Saini S, Hahn PF, Brady TJ, Cohen MS. Clinical application of
abominal echoplanar imaging (EPI):optimization using a retrofitted
EPI system. J Comput Asist Tomogr 1994; 18: 673-9.
- Stejskal EO, Taner JE. Spin diffusion measurements: spin-echo in the
presence of a time dependent field gradient. J Chem Phys 1965; 42:
288-92.
- Galea N, Cantisani V, Taouli B. Liver lesion detection and characterization:
role of diffusion-weighted imaging. J Magn Reson Imaging
2013; 37: 1260-76.
- Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology
2010; 254: 47-66.
- Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y. Evaluation of
liver diffusion isotropy and characterization of focal hepatic lesions
with two single-shot echo-planar MR imaging sequences: prospective
study in 66 patients. Radiology 2003; 226: 71-8.
- Koh DM, Padhani AR. Diffusion-weighted MRI: a new functional clinical
technique for tumour imaging. Br J Radiol 2006; 79: 633-5.
- Papanikolaou N, Gourtsoyianni S, Yarmenitis S, Maris T, Gourtsoyiannis
N. Comparison between two-point and four-point methods
for quantification of apparent diffusion coefficient of normal liver
parenchyma and focal lesions. Value of normalization with spleen.
Eur J Radiol 2010; 73: 305-9.
- Goshima S, Kanematsu M, Kondo H, Yokoyama R, Kajita K, Tsuge Y,
et al. Diffusion-weighted imaging of the liver: optimizing b value for
the detection and characterization of benign and malignant hepatic
lesions. J Magn Reson Imaging 2008; 28: 691-7.
- Chen ZG, Xu L, Zhang SW, Huang Y, Pan RH. Lesion discrimination
with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.
World J Gastroenterol 2015; 21: 1621-7.
- Zech CJ, Grazioli L, Breuer J, Reiser M, Schoenberg SO. Diagnostic
performance and description of morphological features of focal
nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance
imaging: results of a multicenter trial. Investig Radiol 2008;
43: 504-11.
- Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Aisen AM. The
value of diffusion-weighted imaging in characterizing focal liver
masses. Acad Radiol 2009; 16: 1208-14.
- Hennedige TP, Hallinan JT, Leung FP, Teo LL, Iyer S, Wang G, et
al. Comparison of magnetic resonance elastography and diffusion-weighted
imaging for differentiating benign and malignant
liver lesions. Eur Radiol 2016; 26: 398-406.
- Wei C, Tan J, Xu L, Juan L, Zhang SW, Wang L, et al. Differential diagnosis
between hepatic metastases and benign focal lesions using
DWI with parallel acquisition technique: a meta-analysis. Tumour
Biol 2015; 36: 983-90.
- Bruix J, Sherman M. American Association for the Study of Liver Diseases.
Management of hepatocellular carcinoma: an update. Hepatology
2011; 53: 1020-2.
- Kanematsu M, Goshima S, Watanabe H, Kondo H, Kawada H, Noda
Y, et al. Detection and characterization of focal hepatic lesions with
diffusion-weighted MR imaging: a pictorial review. Abdom Imaging
2013; 38: 297-308.
- Schmid-Tannwald C, Thomas S, Ivancevic MK, Dahi F, Rist C, Sethi
I, et al. Diffusion-weighted MRI of metastatic liver lesions: is there
a difference between hypervascular and hypovascular metastases?
Acta Radiol 2014; 55: 515-23.
- Lebovici A, Sfrangeu SA, Feier D, Caraiani C, Lucan C, Suciu M, et al.
Evaluation of the normal- to-diseased apparent diffusion coefficient
ratio as an indicator of prostate cancer aggressiveness. BMC Med
Imaging 2014; 14: 15.
- Caraiani C, Chiorean L, Fenesan DI, Lebovici A, Feier D, Gersak M. Diffusion
Weighted Magnetic Resonance Imaging for the Classification
of Focal Liver Lesions as Benign or Malignant. J Gastrointestin Liver
Dis 2015; 24: 309-17.